Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Lymphoma, Large B-Cell, Diffuse 97Leukemia, Lymphocytic, Chronic, B-Cell 88Lymphoma, Follicular 81Lymphoma 62Lymphoma, Mantle-Cell 59Lymphoma, B-Cell, Marginal Zone 47Lymphoma, Non-Hodgkin 46Recurrence 35Lymphoma, B-Cell 24Leukemia 20Waldenstrom Macroglobulinemia 18Hodgkin Disease 18Lymphoma, T-Cell, Peripheral 16Burkitt Lymphoma 14Lymphoma, T-Cell, Cutaneous 12Lymphoma, T-Cell 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Sezary Syndrome 10Mycosis Fungoides 10Multiple Myeloma 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, Large-Cell, Anaplastic 9Immunoblastic Lymphadenopathy 8Lymphoma, Large-Cell, Immunoblastic 7Intraocular Lymphoma 7Neoplasms 6Lymphoma, Extranodal NK-T-Cell 6Leukemia, B-Cell 6Leukemia, Hairy Cell 5Leukemia-Lymphoma, Adult T-Cell 4

Interventions

liposomal amphotericin B 2Caspofungin 2ofatumumab 1Vancomycin 1Tazobactam 1Surveys and Questionnaires 1Ritonavir 1Quality of Life 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Moxifloxacin 1Metformin 1Mannose-Binding Lectin 1Levofloxacin 1Lenalidomide 1Ciprofloxacin 1Cefepime 1Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fever × Lenalidomide × Lymphoid × Clear all
NCT01002755 2019-05-07

Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

M.D. Anderson Cancer Center

Phase 2 Completed
36 enrolled 7 charts
Classical hematologyLymphoidOther hematologic neoplasm

Lymphadenopathy, Agammaglobulinemia, Fatigue, Fever, Lymphocytosis, Paraproteinemias, Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡